Transcatheter aortic valve implantation in patients at intermediate surgical risk

C Spaccarotella, A Mongiardo, S De Rosa… - International Journal of …, 2017 - Elsevier
… for TAVI to the intermediate-risk population has been attracting … in both high- and
intermediate-risk patients with severe AS. … on the use of TAVI in patient at intermediate-risk for …

Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation

P Wenaweser, S Stortecky, S Schwander… - European heart …, 2013 - academic.oup.com
valve implantation (TAVI) is an established treatment alternative to surgical aortic valve
replacement in high-risk … patients with estimated low or intermediate risk remain to be determined…

Systematic review and meta-analysis to compare outcomes between intermediate-and high-risk patients undergoing transcatheter aortic valve implantation

K Singh, AS Bhalla, MA Qutub, K Carson… - … Heart Journal-Quality …, 2017 - academic.oup.com
… Transcatheter aortic valve implantation in intermediate-risk patients carries a low mortality
and high success. Incidence of pacemaker and stroke remains high in the lower risk group. …

Transcatheter aortic valve implantation in intermediate surgical risk patients with severe aortic stenosis: a systematic review and meta-analysis

K Singh, K Carson, MK Rashid, R Jayasinghe… - Heart, Lung and …, 2018 - Elsevier
… TAVI to low and intermediate risk groups in the current environment of financial constraints.
valve implantation is currently a more expensive option than surgery due to the cost of valves

Patients at intermediate surgical risk undergoing isolated interventional or surgical aortic valve implantation for severe symptomatic aortic valve stenosis: one-year …

N Werner, R Zahn, A Beckmann, T Bauer, S Bleiziffer… - Circulation, 2018 - Am Heart Assoc
… patients at intermediate surgical risk may undergo either isolated TAVR or surgical aortic
valve … In a propensity score analysis, 1-year mortality rates of TAVR and surgical aortic valve

[HTML][HTML] Transcatheter versus surgical aortic valve replacement in intermediate risk patients: a meta-analysis

S Arora, JA Misenheimer, W Jones… - Cardiovascular …, 2016 - ncbi.nlm.nih.gov
… , Web of Science and Cochrane databases for studies with key words transcatheter, transact
heter aortic valve implantation, percutaneous aortic valve implantation, percutaneous aortic …

[HTML][HTML] Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low and intermediate risk: A risk specific meta-analysis of …

F Fang, J Tang, Y Zhao, J He, P Xu, A Faramand - PloS one, 2019 - journals.plos.org
valves, transcatheter aortic valve implantation (TAVI) has rapidly become the treatment of
choice for patients with inoperable and high-risk … low to intermediate surgical risk patients. As …

Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic …

S Kodali, VH Thourani, J White… - European heart …, 2016 - academic.oup.com
… Echocardiographic analyses utilize the valve implant population (ie those who actually
received the valve). Categorical variables were summarized as percentages while continuous …

[HTML][HTML] Causes of death in intermediate-risk patients: the randomized surgical replacement and transcatheter aortic valve implantation trial

H Amrane, GM Deeb, JJ Popma, SJ Yakubov… - The Journal of Thoracic …, 2019 - Elsevier
… This analysis found similar survival for intermediate-risk patients undergoing TAVR and
SAVR during 3 time periods through 1 year. Results suggest that survival may primarily be …

Outcomes of patients at estimated low, intermediate, and high risk undergoing transcatheter aortic valve implantation for aortic stenosis

IM Barbash, A Finkelstein, A Barsheshet… - The American journal of …, 2015 - Elsevier
… excluded from earlier transcatheter aortic valve implantation (TAVI) clinical … intermediate-
and low-risk patients is safe and associated with improved outcome compared with high-risk